X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF GLAUCOMA

期刊標題檢索 J GLAUCOMA 最新評論: Choose the journal that you want to switch to from the same publisher,... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF GLAUCOMA]您好,您是該頁面的第 13486 位訪客。

期刊簡介
期刊名稱JOURNAL OF GLAUCOMA JOURNAL OF GLAUCOMA
LetPub Score
5.2
50 ratings
Rate

Reputation
6.2

Influence
4.0

Speed
7.0

期刊簡稱J GLAUCOMA
ISSN1057-0829
E-ISSN1536-481X
h-index80
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.200.9951.032
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Ophthalmology
Q238 / 137

自引率 (2023-2024)15.00%自引率趨勢
掲載範囲
The Journal of Glaucoma is a peer reviewed journal addressing the spectrum of issues affecting definition, diagnosis, and management of glaucoma and providing a forum for lively and stimulating discussion of clinical, scientific, and socioeconomic factors affecting care of glaucoma patients.
官方網站http://journals.lww.com/glaucomajournal/pages/default.aspx
在線稿件提交https://www.editorialmanager.com/JOG
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1992
每年文章數173每年文章數趨勢
黃金OA百分比29.41%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
OPHTHALMOLOGYSCIEQ238/95
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1057-0829%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【JOURNAL OF GLAUCOMA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PROGRESS IN RETINAL AND EYE RESEARCHH-index: 131

    CiteScore: 34.10
    OPHTHALMOLOGYH-index: 217

    CiteScore: 22.30
    Ocular SurfaceH-index: 53

    CiteScore: 11.60
    SURVEY OF OPHTHALMOLOGYH-index: 120

    CiteScore: 10.30
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEH-index: 196

    CiteScore: 6.90
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGYH-index: 67

    CiteScore: 7.60
    AMERICAN JOURNAL OF OPHTHALMOLOGYH-index: 171

    CiteScore: 9.20
    BRITISH JOURNAL OF OPHTHALMOLOGYH-index: 137

    CiteScore: 10.30
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIEH-index: 44

    CiteScore: 3.20
    ACTA OPHTHALMOLOGICAH-index: 77

    CiteScore: 7.60
    學科內最受檢索的期刊 頁面查看次數
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE67701
    OPHTHALMOLOGY43607
    EXPERIMENTAL EYE RESEARCH43428
    BRITISH JOURNAL OF OPHTHALMOLOGY41018
    EYE40969
    CURRENT EYE RESEARCH38548
    CORNEA37646
    ACTA OPHTHALMOLOGICA37084
    AMERICAN JOURNAL OF OPHTHALMOLOGY35757
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY33308
  •  

    JOURNAL OF GLAUCOMA JOURNAL OF GLAUCOMA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [JOURNAL OF GLAUCOMA] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:10:05 評論於
Choose the journal that you want to switch to from the same publisher, and submit your manuscript according to the submission guidelines of that journal
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:21:06 評論於
The corresponding author of an SCI journal article does not necessarily have to be only one person, and there is no fixed standard for how many there can be. This is because different SCI journals have different policies on the number of corresponding authors. For SCI journals that only recognize one corresponding author, if the paper lists multiple corresponding authors, the first corresponding author will automatically be chosen. For SCI journals that recognize two corresponding authors, two corresponding authors can be listed. The same applies to other requirements, meaning that the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experimentation and writing of the article, and is the person whose name appears first in the list of authors. In collaborative works, it is common for there to be joint first authors. As for the number of joint first authors, there is no clear regulation and it largely depends on factors such as the workload of the paper, its length, the regulations of the publishing journal, and the recognition of the authors' affiliations. Generally speaking, having 2-4 first authors in an SCI paper is the most common situation
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 10:40:12 評論於
How to transfer to different journals within the same publishing house?
(0) 讚! | 陶宜三岁啦

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 14:50:06 評論於
How many corresponding authors can there be at most? How many first authors can there be at most?
(0) 讚! | 上清雨真

作者: 梦华三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-18 10:48:42 評論於
Short cycle, faster feedback
(0) 讚! | 梦华三岁啦

作者: 龙鳞新玲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-01-08 08:41:01 評論於
The review process is too slow, it took 1 and a half months to be with the editor, over 2 months to be under review, and it was rejected after more than 4 months
(0) 讚! | 龙鳞新玲

作者: Emily Swinburne


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-09-09 11:25:45 評論於
Review speed: 12.0
Experience sharing: Submitted two months ago and the status has always been "with editor". Later, the editor replied saying that there are too many submissions now and the average review period is 6-8 months
(0) 讚! | Emily Swinburne

作者: 南川微澜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-08-04 22:57:40 評論於
It is easy to hit the target when submitting an article, and the cycle is short
(0) 讚! | 南川微澜

作者: 南川微澜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-08-02 09:18:46 評論於
SCI(2009): 1.744 SCI(2008): 2.078 SCI(2007): 1.832
(0) 讚! | 南川微澜

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [JOURNAL OF GLAUCOMA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*